Data on the association between vitamin D status and actual change in glycemic measures are limited. We examined the prospective association between a predicted 25-hydroxyvitamin D (25(OH)D) score and change in fasting plasma glucose concentration over a mean follow-up of 7 years, in 2571 men and women (mean age 54 years) without diabetes in the Framingham Offspring Study cohort. After adjustment for age, sex, body mass index and fasting plasma glucose at baseline, higher predicted 25(OH)D score at baseline was associated with a smaller 7-year increase in fasting plasma glucose concentrations (0.23 mmol/l versus 0.35 mmol/l for highest versus lowest tertile of 25(OH)D score, respectively, P-trend ¼ 0.002). Vitamin D status may be an important determinant for change in fasting plasma glucose concentration among middle-aged and older adults without diabetes.
Introduction
There is accumulating evidence to suggest that poor vitamin D status is associated with a higher risk of type 2 diabetes (Pittas et al., 2006 (Pittas et al., , 2007b Mattila et al., 2007) , but little information exists on the association between vitamin D status and change in glycemic measures (Forouhi et al., 2008) . The purpose of the current study was to examine the prospective relationship between a predicted 25-hydroxyvitamin D (25(OH)D) score (Liu et al., 2010) and changes in fasting plasma glucose concentrations among adults without type 2 diabetes.
Subjects and methods
A total of 3295 members of the Framingham Offspring cohort participated in the 5th study examination (1991) (1992) (1993) (1994) (1995) , baseline for the present study, and the 7th (follow-up) examination (1998) (1999) (2000) (2001) . The cohort was essentially all white. We excluded participants based on a previous diagnosis of diabetes (n ¼ 186), use of insulin or oral hypoglycemic medication (n ¼ 53), or elevated glucose levels (fasting X7.0 mmol/l or 2-hour post-challenge X11.1 mmol/l; n ¼ 107), invalid food frequency questionnaires (n ¼ 262), and missing data on body mass index (BMI) (n ¼ 102) or fasting plasma glucose concentration (n ¼ 14). After these exclusions, 1156 men and 1415 women remained. Those included were younger (54.3 versus 55.6 years) than those excluded. No significant differences were observed between those excluded and included with respect to sex, BMI and smoking. The Institutional Review Boards for Human Research at Boston University and Tufts Medical Center approved the study protocols.
The development of the predicted 25(OH)D score, described in detail elsewhere (Liu et al., 2010) (Giovannucci et al., 2006; Bao et al., 2010) .
We used this regression model to calculate predicted 25(OH)D scores at baseline for each participant. To adjust for the seasonal effect, we assumed all blood samples were collected in May when we calculated the score.
Fasting plasma glucose concentrations were measured in fresh specimens (A-gent glucose test, Abbott Laboratories Inc., South Pasadena, CA, USA). Assays were performed in duplicate (coefficient of varianceso3%).
Statistical analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC, USA). Analysis of covariance was used to examine the change in fasting glucose concentrations across tertile categories of the predicted 25(OH)D score. Multiple linear regression models treating the median predicted 25(OH)D score in each tertile category as a continuous variable were used to calculate the P-values for linear trend. Covariates included age, sex, baseline BMI and fasting plasma glucose concentrations, and change in BMI during follow-up. Additional covariates (diet quality, alcohol consumption, physical activity score and smoking) had no effect on the association, and, therefore, were not included in the final model. We also considered interactions between fasting glucose levels at baseline and predicted 25(OH)D scores to determine if the association is strengthened among those individuals with higher fasting glucose concentrations at baseline.
Results
Those with higher predicted 25(OH)D score were more likely to be older and male, and have a lower BMI. Predicted 25(OH)D score was inversely associated with baseline fasting plasma glucose concentrations (Table 1) .
After adjusting for age, sex and baseline BMI and fasting plasma glucose, and change in BMI during follow-up (Table 1 , model 2), predicted 25(OH)D score was inversely associated with 7-year change in fasting plasma glucose. Compared with those in the lowest tertile category of predicted 25(OH)D score, those in the highest tertile category had a 34% smaller increase in fasting glucose concentrations (0.23 versus 0.35 mmol/l). There was no statistically significant interaction between baseline fasting plasma glucose and 25(OH)D score on change in fasting plasma glucose.
Discussion
In this study, we found that a higher predicted 25(OH)D score was associated with a smaller increase in fasting plasma glucose concentrations over 7 years among participants free of diabetes. This result is consistent with cross-sectional studies that have reported an inverse association between plasma 25(OH)D concentrations and fasting glucose (Scragg et al., 2004; Ford et al., 2005; Need et al., 2005) . Only one other study of non-diabetic adults (Forouhi et al., 2008) examined the prospective association between blood 25(OH)D and plasma glucose concentrations, and reported that serum 25(OH)D concentrations at baseline were inversely associated with a 10-year risk of hyperglycemia. Pittas et al. (2007a) found that combined calcium and vitamin D supplementation in adults X65 years old prevented a rise in fasting plasma glucose in those with impaired fasting glucose but not in those with the normal fasting glucose; however, in the current study, the association between 25(OH)D and change in fasting plasma glucose was independent of baseline fasting plasma glucose. The inconsistency between these findings could be due to effects of calcium on glucose metabolism or the age difference between the study populations. Our finding is also in accord with recent reports (Pittas et al., 2006; Mattila et al., 2007) . Plausible mechanisms by which vitamin D status may affect fasting glucose include: a direct effect of vitamin D on insulin synthesis and secretion in pancreatic b-cells (Lee et al., 1994) ; effects on insulin resistance through parathyroid hormone (PTH) concentrations or insulin receptor expression (Maestro et al., 2000; Nagpal et al., 2009; von Hurst et al., 2010) ; or effects on non-insulin-dependent pathways, such as insulin-independent glucose clearance (Jani et al., 2008) or glucose uptake (Norman, 2006) in fasting state, thereby regulating fasting plasma glucose concentrations in non-diabetic range.
The most apparent limitation of this study is that factors used to calculate the predicted 25(OH)D score are also important risk factors for the outcomes of interest. In order to remove the potential confounding from these factors, we adjusted for these factors in the models, but this may also result in overadjustment, biasing the results toward null. There is limited evidence that PTH may be linked to insulin sensitivity (Alvarez et al., 2010; Soares et al., 2011) . Consequently, we cannot exclude residual confounding from PTH as partial explanation of the observed association.
In summary, our finding adds support for the hypothesis that vitamin D status may be an important determinant for fasting plasma glucose levels within non-diabetic range.
